Edition:
United Kingdom

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

298.90USD
25 Apr 2019
Change (% chg)

$5.12 (+1.74%)
Prev Close
$293.78
Open
$293.36
Day's High
$299.15
Day's Low
$292.33
Volume
36,721
Avg. Vol
57,416
52-wk High
$345.15
52-wk Low
$220.10

Latest Key Developments (Source: Significant Developments)

Bio Rad Laboratories Files For Non-Timely 10-K - SEC Filing
Friday, 2 Mar 2018 

March 2 (Reuters) - Bio Rad Laboratories Inc ::BIO RAD LABORATORIES FILES FOR NON-TIMELY 10-K - SEC FILING.  Full Article

Bio-Rad Authorizes New $250 Million Share Repurchase Program
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM.BIO RAD LABORATORIES INC - ‍NEW SHARE REPURCHASE PROGRAM SUPERSEDES COMPANY'S PRIOR SHARE REPURCHASE PROGRAM​.  Full Article

Bio Rad Laboratories reports Q3 earnings per share $0.91
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Bio Rad Laboratories Inc :Bio Rad Laboratories Inc reports third-quarter 2017 financial results.Q3 earnings per share $0.91.Q3 sales $535 million versus I/B/E/S view $508 million.Sees q4 2017 sales $615 million to $625 million.Q3 earnings per share view $0.38 -- Thomson Reuters I/B/E/S.  Full Article

Bio-Rad reports Q2 earnings per share $0.17
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - Bio Rad Laboratories Inc -:Bio-Rad reports second-quarter 2017 financial results.Q2 earnings per share $0.17.Q2 sales $504.7 million versus i/b/e/s view $515.8 million.Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S.Bio Rad Laboratories Inc - for full year 2017, company continues to anticipate currency-neutral organic sales growth of approximately 4 percent,.Bio Rad Laboratories - lowering estimate for currency-neutral operating profit for fy2017 from 7 percent of sales to now be in 6 to 6.5 percent range​.Bio Rad Laboratories Inc - ‍addition of recently acquired raindance technologies could add up to another 1 percent of growth in sales for FY 2017​.  Full Article

Bio Rad Laboratories receives FDA clearance for Bioplex 2200 syphilis total & RPR assay​
Monday, 12 Jun 2017 

June 12 (Reuters) - Bio Rad Laboratories Inc ::Bio Rad Laboratories Inc - ‍has received U.S. Food and Drug Administration clearance for its Bioplex 2200 syphilis total & RPR assay​.  Full Article